RELAPSE TO INJECTING DRUG USE: A HEPATITIS C TREATMENT CONCERN
Saved in:
HARRIS, M., RELAPSE TO INJECTING DRUG USE: A HEPATITIS C TREATMENT CONCERN. CONTEMPORARY DRUG PROBLEMS, Vol. 36, no. 1-2 (2009), p. 303-326.
Ref.
164064
Location:
SIIS R.1022
Palabras clave:
Drogas ilegales, Drogodependencias, Hepatitis, Recaída, Tratamiento médico, Utilización de servicios, Vía intravenosa
Drogas ilegales, Drogodependencias, Hepatitis, Recaída, Tratamiento médico, Utilización de servicios, Vía intravenosa
Similar Items: RELAPSE TO INJECTING DRUG USE: A HEPATITIS C TREATMENT CONCERN
- FACTORS ASSOCIATED WITH UPTAKE OF TREATMENT FOR RECENT HEPATITIS C VIRUS INFECTION IN A PREDOMINANTLY INJECTING DRUG USER COHORT: THE ATAHC STUDY
- Hepatitis C treatment for injecting drug users
- HEPATITIS C AND THE LIMITS OF MEDICALISATION AND BIOLOGICAL CITIZENSHIP FOR PEOPEL WHO INJECT DRUGS
- INJECTING DRUG USERS' UNDERSTANDING OF HEPATITIS C
- TREATMENT COSTS OF HEPATITIS C INFECTION AMONG INJECTION DRUG USERS IN CANADA, 2006-2026
- Positive impact of hepatitis C virus (HCV) treatment on antiretroviral treatment adherence in human immunodeficiency virus-HCV coinfected patients: one more argument for expanded access to HCV treatment for injecting drug users